MD vs UTMD
MD: National physician services company providing neonatal, maternal-fetal, and pediatric specialty care to 2,300+ affiliated doctors staffing hospital ICUs and maternal-fetal units across 37 states. UTMD: Utah Medical Products designs and manufactures specialized medical devices focused on patient safety in critical care, neonatal intensive care, and women's health.
Side-by-side fundamentals
| Metric | MD | UTMD | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $25.83 | $69.19 | |
| Market cap as of 2026-07-23 | $2.1B | $220M | |
| P/E as of 2026-07-23 | 12.14 | 20.29 | MD lower |
| Net margin as of 2026-07-23 | +9.0% | +28.9% | UTMD higher |
| Gross margin as of 2026-07-23 | n/a | +57.9% | |
| Operating margin as of 2026-07-23 | +12.4% | +28.8% | UTMD higher |
| ROE as of 2026-07-23 | +20.1% | +9.1% | MD higher |
| ROA as of 2026-07-23 | +8.1% | +8.9% | UTMD higher |
| Debt / equity as of 2026-07-23 | 0.67 | 0.00 | UTMD lower |
| Revenue growth (YoY) as of 2026-07-23 | -2.3% | -4.4% | MD higher |
| Revenue CAGR (3y) SEC XBRL | n/a | -9.7% | |
| Dividend yield as of 2026-07-23 | n/a | +1.8% | |
| Beta as of 2026-07-23 | 0.65 | 0.36 | |
| 1-year return as of 2026-07-22 close | +102.7% | +22.6% | MD higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.